Drug-induced oral dyskinesias in rats after traditional and new neuroleptics

T. Kakigi, X. M. Gao, C. A. Tamminga

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Tardive dyskinesia (TD) is a serious human side effect of neuroleptic treatment in psychotic disorders. Although the etiology is clear (ie. chronic neuroleptic drugs), its pathophysiology has not yet been satisfactorily explained. This is important not only theoretically but also to inform drug development, allowing the introduction of antipsychotic compounds without TD liability. The development of an animal condition which putatively models these delayed onset dyskinesias, has provided a technique to differentiate between neuroleptic drug effect and dyskinesia correlates. We report here the development of oral dyskinesias in rats in response to a number of different neuroleptics, which have a range of neurochemical and clinical characteristics. Traditional neuroleptics (e.g. haloperidol) produced rat oral dyskinesias, in an open-cage environment. Clozapine, while it produced an increased rate of oral movements, showed a significantly decreased potency in this model. SCH23390 (D1 antagonist) neither produced the oral movements nor modified their onset by coadministration with raclopride. These data replicate and extend other similar studies in the literature. They suggest that clozapine differs from traditional neuroleptics with respect to motor side effects.

Original languageEnglish (US)
Pages (from-to)41-49
Number of pages9
JournalJournal of Neural Transmission
Volume101
Issue number1-3
DOIs
StatePublished - Feb 1995

Fingerprint

Drug-Induced Dyskinesia
Movement Disorders
Antipsychotic Agents
Clozapine
Dyskinesias
Raclopride
Haloperidol
Psychotic Disorders

Keywords

  • antipsychotic medications
  • atypical neuroleptics
  • clozapine
  • haloperidol
  • Tardive dyskinesia

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Drug-induced oral dyskinesias in rats after traditional and new neuroleptics. / Kakigi, T.; Gao, X. M.; Tamminga, C. A.

In: Journal of Neural Transmission, Vol. 101, No. 1-3, 02.1995, p. 41-49.

Research output: Contribution to journalArticle

@article{caf73a0dd42843eaa6d51e3ebb782811,
title = "Drug-induced oral dyskinesias in rats after traditional and new neuroleptics",
abstract = "Tardive dyskinesia (TD) is a serious human side effect of neuroleptic treatment in psychotic disorders. Although the etiology is clear (ie. chronic neuroleptic drugs), its pathophysiology has not yet been satisfactorily explained. This is important not only theoretically but also to inform drug development, allowing the introduction of antipsychotic compounds without TD liability. The development of an animal condition which putatively models these delayed onset dyskinesias, has provided a technique to differentiate between neuroleptic drug effect and dyskinesia correlates. We report here the development of oral dyskinesias in rats in response to a number of different neuroleptics, which have a range of neurochemical and clinical characteristics. Traditional neuroleptics (e.g. haloperidol) produced rat oral dyskinesias, in an open-cage environment. Clozapine, while it produced an increased rate of oral movements, showed a significantly decreased potency in this model. SCH23390 (D1 antagonist) neither produced the oral movements nor modified their onset by coadministration with raclopride. These data replicate and extend other similar studies in the literature. They suggest that clozapine differs from traditional neuroleptics with respect to motor side effects.",
keywords = "antipsychotic medications, atypical neuroleptics, clozapine, haloperidol, Tardive dyskinesia",
author = "T. Kakigi and Gao, {X. M.} and Tamminga, {C. A.}",
year = "1995",
month = "2",
doi = "10.1007/BF01271544",
language = "English (US)",
volume = "101",
pages = "41--49",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer Verlag",
number = "1-3",

}

TY - JOUR

T1 - Drug-induced oral dyskinesias in rats after traditional and new neuroleptics

AU - Kakigi, T.

AU - Gao, X. M.

AU - Tamminga, C. A.

PY - 1995/2

Y1 - 1995/2

N2 - Tardive dyskinesia (TD) is a serious human side effect of neuroleptic treatment in psychotic disorders. Although the etiology is clear (ie. chronic neuroleptic drugs), its pathophysiology has not yet been satisfactorily explained. This is important not only theoretically but also to inform drug development, allowing the introduction of antipsychotic compounds without TD liability. The development of an animal condition which putatively models these delayed onset dyskinesias, has provided a technique to differentiate between neuroleptic drug effect and dyskinesia correlates. We report here the development of oral dyskinesias in rats in response to a number of different neuroleptics, which have a range of neurochemical and clinical characteristics. Traditional neuroleptics (e.g. haloperidol) produced rat oral dyskinesias, in an open-cage environment. Clozapine, while it produced an increased rate of oral movements, showed a significantly decreased potency in this model. SCH23390 (D1 antagonist) neither produced the oral movements nor modified their onset by coadministration with raclopride. These data replicate and extend other similar studies in the literature. They suggest that clozapine differs from traditional neuroleptics with respect to motor side effects.

AB - Tardive dyskinesia (TD) is a serious human side effect of neuroleptic treatment in psychotic disorders. Although the etiology is clear (ie. chronic neuroleptic drugs), its pathophysiology has not yet been satisfactorily explained. This is important not only theoretically but also to inform drug development, allowing the introduction of antipsychotic compounds without TD liability. The development of an animal condition which putatively models these delayed onset dyskinesias, has provided a technique to differentiate between neuroleptic drug effect and dyskinesia correlates. We report here the development of oral dyskinesias in rats in response to a number of different neuroleptics, which have a range of neurochemical and clinical characteristics. Traditional neuroleptics (e.g. haloperidol) produced rat oral dyskinesias, in an open-cage environment. Clozapine, while it produced an increased rate of oral movements, showed a significantly decreased potency in this model. SCH23390 (D1 antagonist) neither produced the oral movements nor modified their onset by coadministration with raclopride. These data replicate and extend other similar studies in the literature. They suggest that clozapine differs from traditional neuroleptics with respect to motor side effects.

KW - antipsychotic medications

KW - atypical neuroleptics

KW - clozapine

KW - haloperidol

KW - Tardive dyskinesia

UR - http://www.scopus.com/inward/record.url?scp=0029080253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029080253&partnerID=8YFLogxK

U2 - 10.1007/BF01271544

DO - 10.1007/BF01271544

M3 - Article

C2 - 8695056

AN - SCOPUS:0029080253

VL - 101

SP - 41

EP - 49

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 1-3

ER -